Res-ET intervention for Stroke

"This research mandates that participants are located between 18 and 55 years old. There exist 41 seperate studies for people below the age of majority, while 1013 clinical trials focus on those above retirement age."

"The principle outcome metric monitored over the duration of this 12-month trial is to evaluate the feasibility, acceptability and adherence of Res-ET intervention. Secondary objectives include assessing demographic variables via summary statistics, measuring resilience using UW Resilience Scale with paired t-tests from pre/post intervention data, as well as gauging psychosocial changes in young stroke survivors post-Res-ET. Bonferroni correction will be employed to account for type 1 error when conducting statistical significance tests at a 0.05 level while also calculating mean values, standard deviations, normalities and MCIDs (minimal clinically important differences)."

"Affirmative. Clinicaltrials.gov data suggests that this medical experiment, first published on May 1st 2022, is actively calling for participants. Approximately 20 patients must be enrolled from one site specifically."

"This medical trial is searching for up to 20 individuals who experienced a stroke and are between 18-55 years of age."

"Affirmative, the clinicaltrials.gov website points to this medical trial as actively enrolling participants. This study was posted on May 1st 2022 and most recently updated April 22nd of that same year. The research team is aiming to involve 20 individuals at one distinct site."